![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 34, 23477-23482, 12, 1991
EN Unemori, MJ Bair, EA Bauer and EP Amento
The expression of collagenolytic activity by cells represents the rate-
limiting step in the turnover of collagen during remodeling. The
collagenase gene is transcriptionally activated in normal dermal or
rheumatoid synovial fibroblasts by interleukin-1 beta (IL-1 beta),
resulting in secretion of trypsin-activatable procollagenase measuring in
the range of 2.0-5.0 units/10(6) cells/48 h in the 14C-fibril assay. The
addition of interferon-gamma (IFN-gamma; 50-100 units/ml) inhibits the
expression of collagenase activity by 45-80% in these cells. The IL- 1 beta
induction of procollagenase protein was not altered by IFN- gamma, as
judged by Western blot analysis using a monoclonal antibody to collagenase
and by gelatin zymography, and procollagenase mRNA was also unaltered, as
assessed by Northern blot analysis. Because collagenolytic activity is also
controlled by the quantity of tissue inhibitor of metalloproteinases
present, its expression was examined by Western blot analysis using a
polyclonal antibody to tissue inhibitor of metalloproteinases and by
reverse gelatin zymography. Tissue inhibitor of metalloproteinase protein
was found to be unaltered or slightly less abundant in conditioned media
from cultures treated with IL-1 beta and IFN-gamma when compared with that
from cultures treated with IL-1 beta alone. However, the expression of the
metalloproteinase activator of procollagenase, stromelysin, was found to be
significantly inhibited by the addition of IFN-gamma. Addition of purified
activated stromelysin to these conditioned media completely reconstituted
collagenolytic activity. These observations demonstrate in an intact system
that stromelysin is a specific activator necessary for the development of
collagenolytic activity. Despite stromelysin's lack of catalytic activity
against collagen, its expression can serve as a control point in the
regulation of collagenolysis.
Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma
Department of Developmental Biology, Genentech, South San Francisco, California 94080.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. H. Ho, T. T. Antoniv, J.-D. Ji, and L. B. Ivashkiv Lipopolysaccharide-Induced Expression of Matrix Metalloproteinases in Human Monocytes Is Suppressed by IFN-{gamma} via Superinduction of ATF-3 and Suppression of AP-1 J. Immunol., October 1, 2008; 181(7): 5089 - 5097. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Lauder, S. M. Carty, C. E. Carpenter, R. J. Hill, F. Talamas, J. Bondeson, P. Brennan, and A. S. Williams Interleukin-1{beta} induced activation of nuclear factor-{kappa}b can be inhibited by novel pharmacological agents in osteoarthritis Rheumatology, May 1, 2007; 46(5): 752 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cozlin, S. Barthelemy, R. Garnotel, F. Antonicelli, H. Kaplan, W. Hornebeck, and S. Lorimier Elastolysis Induces Collagenolysis in a Gingival Lamina Propria Model. J. Dent. Res., August 1, 2006; 85(8): 745 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Addis-Lieser, J. Kohl, and M. G. Chiaramonte Opposing Regulatory Roles of Complement Factor 5 in the Development of Bleomycin-Induced Pulmonary Fibrosis J. Immunol., August 1, 2005; 175(3): 1894 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Lent, K. C. Nabbe, P. Boross, A. B. Blom, J. Roth, A. Holthuysen, A. Sloetjes, S. Verbeek, and W. van den Berg The Inhibitory Receptor Fc{gamma}RII Reduces Joint Inflammation and Destruction in Experimental Immune Complex-Mediated Arthritides Not Only by Inhibition of Fc{gamma}RI/III but Also by Efficient Clearance and Endocytosis of Immune Complexes Am. J. Pathol., November 1, 2003; 163(5): 1839 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Tchetverikov, L R Lard, J DeGroot, N Verzijl, J M TeKoppele, F C Breedveld, T W J Huizinga, and R Hanemaaijer Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis Ann Rheum Dis, November 1, 2003; 62(11): 1094 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Stallmach, C C Chan, K-W Ecker, G Feifel, H Herbst, D Schuppan, and M Zeitz Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis Gut, September 1, 2000; 47(3): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meisser, D. Chardonnens, A. Campana, and P. Bischof Effects of tumour necrosis factor-{alpha}, interleukin-1 {alpha}, macrophage colony stimulating factor and transforming growth factor ß on trophoblastic matrix metalloproteinases Mol. Hum. Reprod., March 1, 1999; 5(3): 252 - 260. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |